CURRAX PHARMACEUTICALS LLC v. AUROLIFE PHARMA LLC > Summary
Court Case Number 1:21-cv-20765
Filing Date Dec 30, 2021
Court New Jersey District Court
Status Unknown
JudgesChristine P. Ohearn, Matthew J. Skahill, Elizabeth A. Pascal
Plaintiff
Defendant
Plaintiff Attorneys
7Currax Pharmaceuticals LLC
Attorney Name: Katelyn O'Reilly
Walsh Pizzi O’Reilly Falanga LLP
Currax Pharmaceuticals LLC
Attorney Name: Liza M. Walsh
Walsh Pizzi O’Reilly Falanga LLP
Currax Pharmaceuticals LLC
Attorney Name: Dominick A Conde
Venable
Currax Pharmaceuticals LLC
Attorney Name: Stephen Joseph Krachie
Venable
Currax Pharmaceuticals LLC
Attorney Name: Zachary L. Garrett
Venable
Currax Pharmaceuticals LLC
Attorney Name: Christopher P. Borello
Venable
Defendant Attorneys
3AuroMedics Pharma
Attorney Name: R Touhey Myer
Kratz & Barry
AuroMedics Pharma
Attorney Name: Michael P. Hogan
Kratz & Barry
AuroMedics Pharma
Attorney Name: Timothy H. Kratz
Kratz & Barry
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10272083 | Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor | Apr 30, 2019 |
| 10239883 | 4-imidazopyridazin-1-yl-benzamides as BTK inhibitors | Mar 26, 2019 |
| 10167291 | Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide | Jan 1, 2019 |
| 09796721 | Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide | Oct 24, 2017 |
| 09758524 | 4-imidazopyridazin-1-yl-benzamides as Btk inhibitors | Sep 12, 2017 |
| 09290504 | 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as Btk inhibitors | Mar 22, 2016 |
| 07459554 | Imidazopyrazine tyrosine kinase inhibitors | Dec 2, 2008 |
